Abstract

Human cytomegalovirus (HCMV) is a ubiquitous pathogen that can cause disability in newborns and serious clinical diseases in immunocompromised patients. HCMV has a large genome with enormous coding potential; its viral particles are equipped with complicated glycoprotein complexes and can infect a wide range of human cells. Although multiple host cellular receptors interacting with viral glycoproteins have been reported, the mechanism of HCMV infection remains a mystery. Here we report identification of adipocyte plasma membrane-associated protein (APMAP) as a novel modulator active in the early stage of HCMV infection. APMAP is necessary for HCMV infection in both epithelial cells and fibroblasts; knockdown of APMAP expression significantly reduced HCMV infection of these cells. Interestingly, ectopic expression of human APMAP in cells refractory to HCMV infection, such as canine MDCK and murine NIH/3T3 cells, promoted HCMV infection. Furthermore, reduction in viral immediate early (IE) gene transcription at 6 h post infection and delayed nucleus translocation of tegument delivered pp65 at 4 h post infection were detected in APMAP-deficient cells but not in the wildtype cells. These results suggest that APMAP plays a role in the early stage of HCMV infection. Results from biochemical studies of APMAP and HCMV proteins suggest that APMAP could participate in HCMV infection through interaction with gH/gL containing glycoprotein complexes at low pH and mediate nucleus translocation of tegument pp65. Taken together, our results suggest that APMAP functions as a modulator promoting HCMV infection in multiple cell types and is an important player in the complex HCMV infection mechanism.

Highlights

  • Human cytomegalovirus (HCMV), known as human herpesvirus 5 (HHV-5), is a ubiquitous pathogen belonging to the β-herpesviridae subfamily of the Cytomegalovirus genus

  • Understanding of HCMV infection mechanisms and key host cellular factors involved in viral entry remain elusive, partly due to the complexity of HCMV

  • We report here identification of a type II membrane protein, adipocyte plasma membrane associated protein (APMAP), as a novel modulator promoting HCMV infection

Read more

Summary

Introduction

Human cytomegalovirus (HCMV), known as human herpesvirus 5 (HHV-5), is a ubiquitous pathogen belonging to the β-herpesviridae subfamily of the Cytomegalovirus genus. HCMV infections usually show minor, nonspecific clinical symptoms in healthy individuals and can establish life-long latency in hosts [1]. The virus is frequently linked to congenital infections. The incidence of congenital HCMV infection ranges from 0.3~1.2% worldwide [3]. About 7–10% will suffer from disabilities including mental retardation, loss of hearing or sight, microcephaly, and psychomotor dysfunction [1,4]. Despite close to five decades of effort, no vaccine against HCMV has been licensed. Adverse effects and concerns of viral resistance limit the clinical use of antiviral drugs such as ganciclovir and valganciclovir [5]. An effective preventive vaccine and new potent drugs against HCMV infection are urgently needed. Understanding of viral entry mechanism may provide a new scientific basis for design of novel drugs or vaccines

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call